BridgeMD
New treatment option for Generalized Anxiety Disorder
Official title RCT of Short-Term Psychoanalytic vs. Cognitive Behavioral Therapy for GAD
ClinicalTrials.gov ID: NCT06831708
What this study is testing
- What it's testing
- This study is a randomized controlled trial designed to compare the effectiveness of two types of short-term psychotherapy-psychoanalytic therapy and Cognitive Behavioral Therapy (CBT)-in treating Generalized Anxiety Disorder (GAD). A total of 60 adult participants with a confirmed diagnosis of GAD will be enrolled and randomly assigned to one of three groups: one group will receive psychoanalytic therapy, a second group will receive CBT, and a third group will serve as a control (waiting list) group.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65
You may be able to join if
- Age between 18 and 65 years.
- A confirmed diagnosis of Generalized Anxiety Disorder (GAD) according to DSM-5 criteria, with the diagnosis made within the past 2 years.
- No participation in any form of psychotherapy during the past 6 months.
- Ability and willingness to attend 12 weekly therapy sessions (50 minutes each) over the 3-month intervention period.
- For participants receiving online sessions: access to a stable internet connection and the necessary technology.
You likely can't join if
- Presence of significant comorbid psychiatric disorders that could interfere with participation or assessment (e.g., bipolar disorder, psychotic...
- Recent changes in psychotropic medication (i.e., medication changes within the past 3 months, unless on a stable dose).
- Severe medical or neurological conditions that may interfere with study participation or data interpretation.
- Current participation in another clinical trial or structured psychotherapy program.
- Any condition that, in the opinion of the investigators, would compromise the safety or compliance of the participant in the study.
See the full eligibility criteria
- Age between 18 and 65 years.
- A confirmed diagnosis of Generalized Anxiety Disorder (GAD) according to DSM-5 criteria, with the diagnosis made within the past 2 years.
- No participation in any form of psychotherapy during the past 6 months.
- Ability and willingness to attend 12 weekly therapy sessions (50 minutes each) over the 3-month intervention period.
- For participants receiving online sessions: access to a stable internet connection and the necessary technology.
- Ability to understand and provide written informed consent.
- Presence of significant comorbid psychiatric disorders that could interfere with participation or assessment (e.g., bipolar disorder, psychotic disorders, substance use disorders, eating disorders).
- Recent changes in psychotropic medication (i.e., medication changes within the past 3 months, unless on a stable dose).
- Severe medical or neurological conditions that may interfere with study participation or data interpretation.
- Current participation in another clinical trial or structured psychotherapy program.
- Any condition that, in the opinion of the investigators, would compromise the safety or compliance of the participant in the study.
The study team makes the final eligibility decision.
Where it's taking place
- Istanbul, Turkey (Türkiye)
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Istanbul, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.